Relationship between Adipokines and Cardiovascular Ultrasound Parameters in Metabolic-Dysfunction-Associated Fatty Liver Disease
(1) Background: The role of adipokines such as adiponectin and visfatin in metabolic-dysfunction-associated fatty liver disease (MAFLD) and cardiovascular disease remains unclear. Therefore, we aim to assess serum adiponectin and visfatin levels in MAFLD patients and associated cardiovascular parame...
Main Authors: | Abdulrahman Ismaiel, Mihail Spinu, Livia Budisan, Daniel-Corneliu Leucuta, Stefan-Lucian Popa, Bogdan Augustin Chis, Ioana Berindan-Neagoe, Dan Mircea Olinic, Dan L. Dumitrascu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/21/5194 |
Similar Items
-
Anxiety and Depression in Metabolic-Dysfunction-Associated Fatty Liver Disease and Cardiovascular Risk
by: Abdulrahman Ismaiel, et al.
Published: (2022-04-01) -
Serum Visfatin Levels in Nonalcoholic Fatty Liver Disease and Liver Fibrosis: Systematic Review and Meta-Analysis
by: Abdulrahman Ismaiel, et al.
Published: (2021-07-01) -
Associations between Adipokines and Metabolic Dysfunction-Associated Fatty Liver Disease Using Three Different Diagnostic Criteria
by: Jie Pan, et al.
Published: (2023-03-01) -
The role of adipokines in the disease of metabolic-associated fatty liver disease
by: Chieh Chen
Published: (2023-01-01) -
Updated Clinical Evidence on the Role of Adipokines and Breast Cancer: A Review
by: Georgios-Ioannis Verras, et al.
Published: (2023-03-01)